Mala Murthy - 04 Apr 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Apr 2025, 16:23:48 UTC
Prior SEC filing
21 Mar 2025
Next SEC filing
12 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Mala Murthy filed Form 4 for Teladoc Health, Inc. (TDOC) on 08 Apr 2025.

Key facts

  • This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Apr 2025, 16:23.

Change

  • Previous filing in this sequence was filed on 21 Mar 2025.
  • Current net transaction value: -$51,012.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+12,652
Change %
+11%
Price
Shares after
128,961
Date
04 Apr 2025
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Sale

Transaction value
$51,012
Shares
-7,494
Change %
-5.8%
Price
$6.81
Shares after
121,467
Date
07 Apr 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-12,652
Change %
-33%
Price
$0.000000
Shares after
25,305
Date
04 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,652
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Footnote F3

One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .